Sebriplatin
Alternative Names: CI 973; NK 121Latest Information Update: 01 Aug 1996
At a glance
- Originator Nippon Kayaku
- Class Platinum complexes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer